Amprius secures $21M order for batteries in China e-mobility market

Amprius booked a $21.0M purchase order for SiCore cylindrical cells for light electric vehicles and reported record Q4 revenue of $25.2M (vs $24.5M consensus), driving FY revenue up ~202% to $73M. Q4 revenue grew 137% YoY and EPS was -$0.01 versus an expected -$0.05; analysts (Craig-Hallum, Cantor Fitzgerald) raised price targets to $21 and $20 respectively. Company highlights include 30 Ah silicon-anode cells (claimed up to +100% energy density, >2,000 cycles), >100 new customers and a contract expansion with Nokia Drone Networks/DIU; market cap ~ $2.43B and shares near a 52-week high of $19.76.

Analysis

Silicon-anode wins in the light EV segment are less about headline energy density and more about system-level cost and weight arbitrage for low-cost two/three-wheelers; OEMs that can shave 10–20 kg per vehicle or reduce pack volume by 20–30% can cut BOM and logistics cost, accelerating adoption in emerging-market LSVs over the next 12–36 months. That dynamic favors companies that can secure stable supplies of high-purity silicon precursors, robust yield curves at pilot-to-GWh scale, and partners for cell-to-pack integration; contract manufacturers and electrolyte/SEI specialist suppliers will see a disproportionate order flow uplift as ramp begins.

Key downside is execution risk: scale-up commonly produces step-function cost pressure from yields, calendar fade, and BOS integration that can compress gross margin even as revenues grow; a sensible near-term catalyst list is GWh-scale customer announcements, sequential gross-margin improvement (target >15–20%), and demonstrable calendar life data in real-world LSV programs over 6–18 months. Balance-sheet and dilution risk are material near-term catalysts — a capital raise to build capacity would reset returns and is a high-probability event if contract wins exceed pilot capacity.

Consensus appears to price near-perfect execution and quick margin expansion; a contrarian lens asserts that upside is multi-year but lumpy — short-dated traders should focus on binary catalysts (contracts, capacity build) while longer-term holders should underwrite 20–40% drawdowns tied to dilution or yield slippage. The clean trade is to pay for convexity to the execution path (LEAPs or structured spreads) while hedging financing and technical-risk tails with puts or event-driven short exposure to incumbents whose value depends on graphite-anode demand staying stable.

Key Decisions for Investors

• Initiate a 1–1.5% NAV directional allocation using AMPX Jan 19, 2027 $25 LEAP calls — thesis: capture multi-year silicon-anode adoption; target 2.5x return if company announces >0.5 GWh contracted capacity or sustained gross margins >20% within 12–24 months; max loss = premium paid.
• Tactical near-term trade: buy AMPX Feb 21, 2026 20/35 call spread sized to 0.5% NAV (debit). Rationale: low-cost way to play continued quarterly beats into next two reporting windows; limited downside (premium) with asymmetric upside to 15-point spread width. Exit on a 20%+ move or immediately after the post-earnings run-up.
• Pair trade for material-rotation risk: go long AMPX equity (1% NAV) funded by a 1% NAV short in a legacy graphite-anode/materials name (example: ALB or a battery-materials ETF). Timeframe 12–36 months to capture relative re-rating if silicon displaces graphite for LEV packs; stop-loss if relative performance moves 25% adverse within 6 months or if silicon adoption announcements stall.
• Risk hedge: pre-fund potential dilution by buying AMPX Jan 17, 2025 $12 puts sized to 0.5% NAV or by holding cash equivalents to DPI capital raises. Use this to cap downside from an equity raise or major yield shortfall — expected protection cost is small versus asymmetric dilution risk.